CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
5055.0
1.89%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:25

  • Summary
  • Historical Data
Trading сonditions
Spread 13.1
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011661 %
Charges from full value of position ($-2.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011661%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010562 %
Charges from full value of position ($-2.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010562%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 4961
Open 5057.9
1-Year Change -35.24%
Day's Range 5035.9 - 5084.9
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 15, 2024 5055.0 17.9 0.36% 5037.1 5086.0 5027.9
Nov 14, 2024 4961.0 -87.5 -1.73% 5048.5 5055.0 4926.6
Nov 13, 2024 5069.4 4.4 0.09% 5065.0 5113.9 5020.5
Nov 12, 2024 5064.5 -10.5 -0.21% 5075.0 5182.9 5046.5
Nov 11, 2024 5023.8 -56.7 -1.12% 5080.5 5085.6 4974.6
Nov 8, 2024 5060.8 -13.0 -0.26% 5073.8 5190.9 5039.8
Nov 7, 2024 5045.0 -21.7 -0.43% 5066.7 5109.9 5014.7
Nov 6, 2024 5047.6 12.8 0.25% 5034.8 5092.0 5026.8
Nov 5, 2024 5062.6 7.6 0.15% 5055.0 5065.0 5022.6
Nov 1, 2024 5064.4 -29.6 -0.58% 5094.0 5101.9 5053.5
Oct 31, 2024 5170.9 -8.6 -0.17% 5179.5 5211.8 5149.8
Oct 30, 2024 5210.8 -19.5 -0.37% 5230.3 5259.0 5197.3
Oct 29, 2024 5215.3 16.3 0.31% 5199.0 5267.8 5172.4
Oct 28, 2024 5188.9 70.5 1.38% 5118.4 5203.1 5105.4
Oct 25, 2024 5138.9 9.6 0.19% 5129.3 5145.9 5077.4
Oct 24, 2024 5144.9 58.6 1.15% 5086.3 5156.9 5076.3
Oct 23, 2024 5103.9 -48.4 -0.94% 5152.3 5179.9 5100.3
Oct 22, 2024 5160.0 -42.3 -0.81% 5202.3 5206.8 5135.4
Oct 21, 2024 5253.8 13.5 0.26% 5240.3 5292.6 5226.3
Oct 18, 2024 5316.7 10.5 0.20% 5306.2 5368.7 5299.2

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Eisai Co., Ltd. Company profile

About Eisai Co., Ltd

Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Eisai Co., Ltd revenues increased 13% to Y565.33B. Net income applicable to common stockholders increased 34% to Y60.36B. Revenues reflect Other Business segment increase from Y43.85B to Y92.54B, Pharmaceutical Business segment increase of 3% to Y449.48B, China segment increase of 25% to Y83.14B, America segment increase of 13% to Y125.19B, Asia/Latin America segment increase of 10% to Y38.04B.

Equity composition

FY'99-02 WAS & FY'04 DWAS were estimated. FY'03 DWAS was adjusted to reflect reported DEPS. FY'04-06 1Q&3Q WAS & O/S were estimated. 12/05 DPS estimated. FY'08 Q1&Q3 DWAS were estimated. FY'08 Q1&Q3 WAS = O/S. FY'11 Q3 DWAS estimated.

Industry: Pharmaceuticals (NEC)

エーザイ本館
小石川4-6-10
BUNKYO-KU
TOKYO-TO 112-8088
JP

News

SHIB cryptocurrency logo, showing a cartoon Shiba Inu dog on a coin, over a golden orange background with circuit board graphics detail

Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target

Can Shiba Inu reinvent itself to become a worthy long-term investment?

08:36, 15 November 2024

Trump trades charge as Bitcoin hits $US80,000

Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.

10:48, 13 November 2024

Australian jobs data expected to point to solid labour market conditions

Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.

10:16, 13 November 2024

FOMC cuts interest rates as expected and sticks to its line on future policy

The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.

13:33, 8 November 2024

FOMC and BOE preview: further rate cuts expected

Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.

14:14, 5 November 2024

RBA meeting preview: No change to policy expected as inflation fight continues

The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.

13:35, 4 November 2024

US elections: Trump leads the polls, but tariff talk spooks investors

As the US elections get closer we look at how Trump’s tariff plans could affect markets.

15:02, 22 October 2024

People also watch

Gold

2,563.47 Price
-0.050% 1D Chg, %
Long position overnight fee -0.0173%
Short position overnight fee 0.0091%
Overnight fee time 22:00 (UTC)
Spread 0.60

BTC/USD

90,880.75 Price
-0.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

20,408.80 Price
-2.240% 1D Chg, %
Long position overnight fee -0.0242%
Short position overnight fee 0.0019%
Overnight fee time 22:00 (UTC)
Spread 7.0

ETH/USD

3,116.67 Price
-1.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading